|
16 Companies |
|
12 Products |
|
12 Products |
|
13 Mechanisms of Action |
|
0 Trials |
|
158 News |
|
| «1234» |
- erythromycin / Generic mfg.
Trial primary completion date: Erythromycin in Parkinson's Disease (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=15, Recruiting, Sponsor: Virginia Commonwealth University
Trial primary completion date: Mar 2015 --> Jun 2015
- Trial primary completion date: Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis (clinicaltrials.gov) - Jun 11, 2015
P2, N=50, Recruiting, Sponsor: Göteborg University
Trial primary completion date: Mar 2015 --> Jun 2015 Trial primary completion date: Apr 2015 --> Dec 2015
- Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Phase classification: Placebo Controlled Trial of Botulinum Toxin for Gastroparesis (clinicaltrials.gov) - Jun 9, 2015
P=N/A, N=32, Completed, Sponsor: Temple University
Trial primary completion date: Apr 2015 --> Dec 2015 Phase classification: P3 --> P=N/A
- New trial: Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients (clinicaltrials.gov) - May 19, 2015
P=N/A, N=40, Recruiting, Sponsor: Jens Rikardt Andersen
- Trial completion, Trial primary completion date, Biopsy: Endoscopic Full Thickness Biopsy, Gastric Wall. (clinicaltrials.gov) - May 14, 2015
P=N/A, N=3, Completed, Sponsor: Mayo Clinic
Phase classification: P3 --> P=N/A Active, not recruiting --> Completed | Trial primary completion date: Jun 2014 --> Sep 2014
- |||| Trial completion: Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis (clinicaltrials.gov) - May 12, 2015
P1/2, N=80, Completed, Sponsor: Targacept Inc.
Active, not recruiting --> Completed | Trial primary completion date: Jun 2014 --> Sep 2014 Active, not recruiting --> Completed
- lisinopril / Generic mfg.
Trial completion: Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects (clinicaltrials.gov) - Apr 30, 2015
P1, N=24, Completed, Sponsor: Adil Bharucha
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion, Enrollment change: The Effect of Oxytocin on the Gastric Emptying (clinicaltrials.gov) - Apr 7, 2015
P0, N=12, Completed, Sponsor: Skane University Hospital
Recruiting --> Completed Enrolling by invitation --> Completed | N=20 --> 12
- ||| Trial completion, Enrollment change: Impact of Braun Anastomosis on Reduction in Delayed Gastric Emptying Following Pancreaticoduodenectomy (clinicaltrials.gov) - Feb 27, 2015
P=N/A, N=60, Completed, Sponsor: Yonsei University
Enrolling by invitation --> Completed | N=20 --> 12 Recruiting --> Completed | N=50 --> 60
- Enrollment open, Trial primary completion date: Study of Promethazine for Treatment of Diabetic Gastroparesis (clinicaltrials.gov) - Feb 11, 2015
P2, N=24, Recruiting, Sponsor: Dartmouth-Hitchcock Medical Center
Recruiting --> Completed | N=50 --> 60 Not yet recruiting --> Recruiting | Trial primary completion date: Jul 2015 --> Dec 2015
- | Trial suspension: Self-Propelled Versus Standard Percutaneous Endoscopic Gastrojejunostomy(PEG-J); RCT (clinicaltrials.gov) - Jan 26, 2015
P2, N=60, Suspended, Sponsor: Johns Hopkins University
Not yet recruiting --> Recruiting | Trial primary completion date: Jul 2015 --> Dec 2015 Recruiting --> Suspended
- |||| velusetrag (TD-5108) / Innoviva
Enrollment open: The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study (clinicaltrials.gov) - Jan 8, 2015
P2, N=200, Recruiting, Sponsor: Theravance Biopharma R & D, Inc.
Recruiting --> Suspended Not yet recruiting --> Recruiting
- | Enrollment closed: Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis (clinicaltrials.gov) - Jan 7, 2015
P1/2, N=44, Active, not recruiting, Sponsor: Targacept Inc.
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial primary completion date: Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis (clinicaltrials.gov) - Dec 30, 2014
P2, N=50, Recruiting, Sponsor: Göteborg University
Recruiting --> Active, not recruiting Trial primary completion date: Dec 2014 --> Apr 2015
- Januvia (sitagliptin) / Merck (MSD)
New P2 trial: Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes (clinicaltrials.gov) - Dec 25, 2014
P2, N=20, Not yet recruiting, Sponsor: Royal Adelaide Hospital
- erythromycin / Generic mfg.
Trial primary completion date: Erythromycin in Parkinson's Disease (clinicaltrials.gov) - Dec 19, 2014
P=N/A, N=15, Recruiting, Sponsor: Virginia Commonwealth University
Trial primary completion date: Dec 2014 --> Apr 2015 Trial primary completion date: Sep 2014 --> Mar 2015
- || Trial primary completion date: Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=250, Recruiting, Sponsor: Given Imaging Ltd.
Trial primary completion date: Sep 2014 --> Mar 2015 Trial primary completion date: Jul 2015 --> Jan 2016
- azithromycin / Generic mfg.
Enrollment change: Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis (clinicaltrials.gov) - Dec 5, 2014
P2, N=26, Terminated, Sponsor: University of Florida
Trial primary completion date: Jul 2015 --> Jan 2016 N=37 --> 26
- hydrocortisone / Generic mfg.
Trial primary completion date: Cortisone Treatment for the Prevention of Postoperative Pancreatitis and Pancreatitis-induced Complications After Pancreaticoduodenectomy and Distal Pancreatic Resection (clinicaltrials.gov) - Nov 17, 2014
P2, N=0, Enrolling by invitation, Sponsor: Tampere University Hospital
N=37 --> 26 Trial primary completion date: Apr 2014 --> Mar 2015
- ||||| recanaclotide (IW-9179) / Ironwood Pharma
New P2 trial: Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP) (clinicaltrials.gov) - Nov 13, 2014
P2, N=80, Recruiting, Sponsor: Ironwood Pharmaceuticals, Inc.
- |||| relamorelin (RM-131) / AbbVie
Trial completion: Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis (clinicaltrials.gov) - Oct 24, 2014
P2, N=204, Completed, Sponsor: Rhythm Pharmaceuticals, Inc.
Trial primary completion date: Apr 2014 --> Mar 2015 Active, not recruiting --> Completed
- Trial primary completion date, HEOR: Medico-economic Evaluation of ENTERRA Therapy (clinicaltrials.gov) - Oct 17, 2014
P=N/A, N=220, Active, not recruiting, Sponsor: University Hospital, Rouen
Active, not recruiting --> Completed Trial primary completion date: Jul 2014 --> Oct 2014
- ||||| velusetrag (TD-5108) / Innoviva
New P2 trial: The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study (clinicaltrials.gov) - Oct 17, 2014
P2, N=200, Not yet recruiting, Sponsor: Theravance Biopharma R & D, Inc.
- |||| camicinal (GSK962040) / GSK
Enrollment open: A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis (clinicaltrials.gov) - Sep 22, 2014
P2, N=120, Recruiting, Sponsor: GlaxoSmithKline
Trial primary completion date: Jul 2014 --> Oct 2014 Not yet recruiting --> Recruiting
- Clinical: Billroth II or Roux-en-Y Reconstruction for GJ After PD: Randomized Controlled Trial (PAUDA TRIAL) (clinicaltrials.gov) - Sep 22, 2014
P=N/A, N=80, Recruiting, Sponsor: Hospital Universitari de Bellvitge
- Trial completion, Enrollment change: Antro-pyloro-duodenal Motility in Idiopathic Gastroparesis (clinicaltrials.gov) - Sep 8, 2014
P=N/A, N=32, Completed, Sponsor: University Hospital, Rouen
Not yet recruiting --> Recruiting Recruiting --> Completed | N=50 --> 32
- lisinopril / Generic mfg.
New P1 trial: Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects (clinicaltrials.gov) - Sep 5, 2014
P1, N=24, Recruiting, Sponsor: Adil Bharucha
- ||||| camicinal (GSK962040) / GSK
New P2 trial: A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis (clinicaltrials.gov) - Aug 6, 2014
P2, N=120, Not yet recruiting, Sponsor: GlaxoSmithKline
- | velusetrag (TD-5108) / Innoviva
Trial completion, P2 data: Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis (clinicaltrials.gov) - Aug 1, 2014
P2, N=34, Completed, Sponsor: Theravance Biopharma Antibiotics, Inc.
Recruiting --> Completed | N=50 --> 32 Active, not recruiting --> Completed
- tadalafil / Generic mfg.
Trial withdrawal: Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis (clinicaltrials.gov) - Jul 30, 2014
P4, N=0, Withdrawn, Sponsor: Mark Feinglos
Active, not recruiting --> Completed Terminated --> Withdrawn
- | Trial completion, Enrollment change: Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects (clinicaltrials.gov) - Jul 30, 2014
P2, N=20, Completed, Sponsor: Otsuka Pharmaceutical Co., Ltd.
Terminated --> Withdrawn Recruiting --> Completed | N=36 --> 20
- Trial primary completion date: Pancreaticoduodenectomy With or Without Braun Enteroenterostomy: Comparison of Postoperative Pancreatic Fistula and Delayed Gastric Emptying (clinicaltrials.gov) - Jul 18, 2014
P=N/A, N=304, Recruiting, Sponsor: Johns Hopkins University
Recruiting --> Completed | N=36 --> 20 Trial primary completion date: Dec 2013 --> Dec 2014
- | New P1/2 trial: Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis (clinicaltrials.gov) - Jul 12, 2014
P1/2, N=44, Recruiting, Sponsor: Targacept Inc.
- Trial primary completion date: Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis (clinicaltrials.gov) - Jun 27, 2014
P2, N=50, Recruiting, Sponsor: Göteborg University
Trial primary completion date: Dec 2013 --> Dec 2014 Trial primary completion date: Dec 2013 --> Dec 2014
- |||| camicinal (GSK962040) / GSK
Trial completion: A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying (clinicaltrials.gov) - May 28, 2014
P2, N=57, Completed, Sponsor: GlaxoSmithKline
Trial primary completion date: Dec 2013 --> Dec 2014 Active, not recruiting --> Completed
- ||| camicinal (GSK962040) / GSK
Enrollment closed: A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying (clinicaltrials.gov) - May 14, 2014
P2, N=70, Active, not recruiting, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- || camicinal (GSK962040) / GSK
Trial primary completion date: A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying (clinicaltrials.gov) - May 7, 2014
P2, N=70, Recruiting, Sponsor: GlaxoSmithKline
Recruiting --> Active, not recruiting Trial primary completion date: Mar 2014 --> May 2014
- || camicinal (GSK962040) / GSK
Trial completion date: A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying (clinicaltrials.gov) - May 7, 2014
P2, N=70, Recruiting, Sponsor: GlaxoSmithKline
Trial primary completion date: Mar 2014 --> May 2014 Trial completion date: Mar 2014 --> May 2014
- New P2 trial: Study of Promethazine for Treatment of Diabetic Gastroparesis (clinicaltrials.gov) - May 2, 2014
P2, N=24, Not yet recruiting, Sponsor: Dartmouth-Hitchcock Medical Center
- ||| camicinal (GSK962040) / GSK
Trial initiation date: Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study (clinicaltrials.gov) - Apr 23, 2014
P2, N=150, Recruiting, Sponsor: GlaxoSmithKline
Trial completion date: Mar 2014 --> May 2014 Initiation date: Mar 2014 --> Apr 2014
- |||| camicinal (GSK962040) / GSK
Enrollment open: Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study (clinicaltrials.gov) - Apr 23, 2014
P2, N=150, Recruiting, Sponsor: GlaxoSmithKline
Initiation date: Mar 2014 --> Apr 2014 Not yet recruiting --> Recruiting
- Trial completion: Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis (clinicaltrials.gov) - Apr 23, 2014
P=N/A, N=200, Completed, Sponsor: University of Iowa
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| Enrollment open: Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis (clinicaltrials.gov) - Apr 8, 2014
P=N/A, N=250, Recruiting, Sponsor: Given Imaging Ltd.
Recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion, MRI: Assessment of Gastro-Intestinal Function to a Mixed Meal by Non-invasive Imaging (clinicaltrials.gov) - Apr 7, 2014
P=N/A, N=72, Completed, Sponsor: Nottingham University Hospitals NHS Trust
Not yet recruiting --> Recruiting Recruiting --> Completed
- haloperidol / Generic mfg.
New P4 trial: HATGAS: Haloperidol vs Conventional Therapy for Gastroparesis (clinicaltrials.gov) - Feb 5, 2014
P4, N=36, Recruiting, Sponsor: The University of Texas Health Science Center, Houston
- | Panhematin (hemin) / Lundbeck, Recordati
Enrollment closed, IO biomarker: A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus) (clinicaltrials.gov) - Jan 19, 2014
P2, N=20, Active, not recruiting, Sponsor: Mayo Clinic
Recruiting --> Completed Recruiting --> Active, not recruiting
- | New P2 trial: The Size of the Gastric Remnant as Determinant for Delayed Gastric Emptying After Whipple Resection. (clinicaltrials.gov) - Jan 16, 2014
P2, N=120, Enrolling by invitation, Sponsor: Karolinska University Hospital
- Enrollment closed, Biopsy: Endoscopic Full Thickness Biopsy, Gastric Wall. (clinicaltrials.gov) - Jan 8, 2014
P=N/A, N=3, Active, not recruiting, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- tadalafil / Generic mfg.
Trial termination: Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis (clinicaltrials.gov) - Dec 4, 2013
P4, N=1, Terminated, Sponsor: Mark Feinglos
Recruiting --> Active, not recruiting Recruiting --> Terminated; lack of patients who meet inclusion criteria; there was one screen failure
- Trial termination: The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis (clinicaltrials.gov) - Dec 4, 2013
P=N/A, N=8, Terminated, Sponsor: Rabin Medical Center
Recruiting --> Terminated; lack of patients who meet inclusion criteria; there was one screen failure Not yet recruiting --> Terminated; Completed due to low number of eligible patients